You are hereGroup Leader - Drug Discovery in Advinus Therapeutics - TATA Enterprise

Group Leader - Drug Discovery in Advinus Therapeutics - TATA Enterprise


Advinus Therapeutics (A TATA Enterprise) is an R&D driven company that is focused on the new drug discovery and development of pharmaceutical and agrochemical products.
Advinus operations are organized into two separate businesses centered around Discovery and Development respectively.
The Discovery arm of Advinus integrates under one umbrella the expertise, experience, capabilities and infrastructure needed for Drug Discovery from hit to clinical development candidate. Our presence in India helps us enhance the productivity and efficiency of our agrochemical and pharmaceutical R&D programs to unprecedented levels of cost-effectiveness and quality by bringing together demonstrated world class expertise with the talent and economies of India.

Post: Group Leader - Drug Discovery

Job Description:
    *  Ph.D. in Molecular Biology/Cell biology/Biochemistry/Pharmacology or relevant biomedical sciences 5 years of experience post PhD in the pharmaceutical industry focusing on drug discovery.
    * Should have broad understanding of several therapeutic areas such as metabolic /inflammation with authoritative knowledge of at least one of the disciplines.
    * Demonstrated ability to provide leadership to an interdisciplinary, matrix-oriented drug discovery team
    * Should be an effective communicator with some record of relevant scientific publications and/or patents.

To apply to any of the above mentioned mandates, please email your updated CV at hr@advinus.com

Additional Information:
Education : Ph.D
Experience : 5 years
Location : Pune

Functional Area: RnD

Apply here, hr@advinus.com, jobs@pharmatutor.org

See All   Ph.D Alerts   B.Pharm Alerts  M.Pharm Alerts   Pune Alerts

See All   Other Jobs in our Database

PharmaTutor Placements


PLEASE NOTIFY THAT THIS JOB IS EXPIRED.
FIND LATEST JOBS BY CLICKING LINKS BELOW.

FIND LATEST JOBS

Subscribe to RSS headline updates from:
Powered by FeedBurner